Sökresultat

The Swedish Cancer Society awards Kristian Pietras the Cancer Researcher of the Year 2025 honour. He is a professor of molecular medicine at Lund University and is being recognised for his research on the tumour microenvironment, which has given us the key to understanding how cells in blood vessels and connective tissue interact with tumour cells. The motivation for the Cancer Foundation's ‘Cance

https://www.lucc.lu.se/article/kristian-pietras-named-cancer-researcher-year-2025 - 2025-10-11

Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden’s most common forms of cancer. A research team at Lund University in Sweden has studied a protein that regulates a gene which is linked to metastasis of malignant melanoma. Göran Jönsson a

https://www.lucc.lu.se/article/protein-linked-aggressive-skin-cancer - 2025-10-11

The first evidence was recently presented demonstrating how the immune system can be controlled by directly reprogramming connective tissue cells into immune cells. The discovery provides the opportunity to develop an entirely new strategy for targeted immunotherapy against cancer. Filipe Pereira, research team leader and Molecular Medicine Fellow at the Wallenberg Centre for Molecular Medicine (W

https://www.lucc.lu.se/article/research-project-develop-innovative-strategy-cancer-therapy - 2025-10-11

In recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personalised treatment of lymph nodes in breast cancer patients. The latest results that have now been published in Clinical Cancer Research and BMC Cancer show that up to one in every three operations could be avoided. Photo: Mostphotos Breast canc

https://www.lucc.lu.se/article/fewer-lymph-node-operations-breast-cancer-patients-new-prediction-models - 2025-10-11

In a new national register study from Lund University in Sweden, researchers have studied the link between prostate cancer and infertility. The study, published in the British Medical Journal, includes over one million Swedish men. “Men who seek health care for infertility and assisted reproduction were shown to be at higher risk for prostate cancer than those who had become fathers by natural mea

https://www.lucc.lu.se/article/link-between-assisted-reproduction-and-risk-prostate-cancer - 2025-10-11

Lund researchers Anna Sundlöv and Katarina Sjögreen-Gleisner have developed a method to personalise treatment using a newly approved radioactive cancer drug – by taking images of the drug’s dispersion inside the patient. Their article won the best publication of the year prize awarded by the journal EJNMMI Physics. 177Lutetium-DOTATATE one day after injection (coloured area), overlaid on an x-ray

https://www.lucc.lu.se/article/researchers-lund-receive-prize-publication-year - 2025-10-11

Triple negative breast cancer is an aggressive type of cancer representing approximately nine percent of all breast cancer cases in Sweden. It is more common among younger women, has a high heredity factor and causes more frequent relapses earlier in the course of the disease than other breast cancers. Researchers have applied full genome sequencing to carry out detailed mapping of genetic mutatio

https://www.lucc.lu.se/article/patient-specific-diagnostics-breast-cancers-are-difficult-cure - 2025-10-11

Chronic myeloid leukaemia (CML) is a slowly progressing form of blood cancer that attacks the blood-forming cells in the bone marrow. The condition requires lifelong treatment that can cause severe side effects. Rebecca Warfvinge maps stem cells in patients in the hope of identifying predictive markers for how the patient will react to therapy. She has now received an award of USD 20,000 from the

https://www.lucc.lu.se/article/tailored-therapy-chronic-myeloid-leukaemia - 2025-10-11

The European Research Council today announced the winners of its latest Consolidator Grant competition: 301 top scientists and scholars across Europe. Funding for these researchers, part of the Horizon 2020 research and innovation programme, is worth in total EUR 600 million. Filipe Pereira at Lund University in Sweden is one of the 89 selected researchers, and will be awarded an ERC Consolidator

https://www.lucc.lu.se/article/prestigious-erc-grant-innovative-immunotherapy-research - 2025-10-11

Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature. B cells linked to effective cancer immunotherapyCancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained spec

https://www.lucc.lu.se/article/b-cells-linked-effective-cancer-immunotherapy - 2025-10-11

In a major study of hereditary breast cancer, a global network of researchers (including some from Lund University) has identified over 350 faults in DNA that increase an individual’s risk of developing the disease. The researchers believe that these faults can affect as many as 190 genes. Published in Nature Genetics, a scientific journal, the results are said to be the thus far most comprehensiv

https://www.lucc.lu.se/article/major-study-gives-most-comprehensive-map-breast-cancer-risk - 2025-10-11

In their quest to find new and better methods to make cancer cells more susceptible to treatment, Karin Lindkvist and her research group at Lund University in Sweden are looking into the world of molecules, using the X-rays at the MAX IV laboratory. The researchers believe that limiting the cells' access to sugar will make cancer cells more sensitive to treatment. Karin Lindkvist in the laboratory

https://www.lucc.lu.se/article/researchers-believe-sugar-and-obesity-can-make-cancer-cells-more-difficult-kill - 2025-10-11

In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas. However, it has been a challenge to develop techniques to deliver the RNA molecules into the cells where they have an effect. Researchers at Lund University in Sweden have now developed a sensitive technique that makes it possible to study the delivery in

https://www.lucc.lu.se/article/rna-drugs-one-step-closer-be-being-used-cancer-treatment - 2025-10-11

By preventing sugar uptake, researchers succeeded in increasing the cancer cells’ sensitivity to chemotherapeutic treatment. The studies, led by researchers at Lund University in Sweden, were carried out on cancer cells in a lab environment. The results were recently published in the research journal Haematologica. Just like the body’s cells, cancer cells need energy like the sugar molecule, gluco

https://www.lucc.lu.se/article/starved-cancer-cells-became-more-sensitive-chemotherapy - 2025-10-11

A new way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden. The new technology allows very sensitive, quick and cost-effective identification of cancer biomarkers. The research is published in Nature Communications Biology. Today, every third person will get cancer in their lifetime, and the current trend suggests that in a few years that number will

https://www.lucc.lu.se/article/novel-biomarker-technology-cancer-diagnostics - 2025-10-11

A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to specifically target lung tumors. The new study has been published in the July issue of Advanced Therapeutics. Lung tumors are often difficult to remove using current surgical techniques due to their location in

https://www.lucc.lu.se/article/new-promising-treatment-uses-smart-nanoparticles-target-lung-cancer - 2025-10-11

A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Communications. “Available preclinical eviden

https://www.lucc.lu.se/article/potency-enhancing-drugs-linked-decreased-risks-men-colorectal-cancer - 2025-10-11

Emma Hammarlund was one of six researchers from Lund University in Sweden that was granted five-year starting grants from the European Research Council. Emma Hammarlund, geobiologist and researcher at the Division of Translational Cancer Research, will investigate how life could develop on our planet. The availability of oxygen has long been the prime focus for different hypotheses, however resear

https://www.lucc.lu.se/article/lucc-researcher-receive-erc-starting-grant - 2025-10-11

Researchers at Lund University in Sweden have developed a computational model which is effective in detecting and identifying genetic mutations in breast tumours. The study, the largest of its kind in the world, includes results from over 3 200 patients with breast cancer. The researchers used RNA sequencing, a sensitive, precise tool which has very gradually started to be applied clinically, alth

https://www.lucc.lu.se/article/new-analytical-model-detects-mutations-breast-cancer - 2025-10-11

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 800 children in the US are diagnosed with neuroblastoma, an aggressive cancer of the nervous system that most frequently arises in the adrenal glands

https://www.lucc.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2025-10-11